Oracle vs. IBM: Which Cloud Computing Stock Is the Better Buy?

Oracle’s cloud momentum is strong: Oracle Cloud revenue rose 47% YoY in fiscal 2026 Q4, contributing to total remaining performance obligations of $638B and implying continued accelerating cloud growth. However, reliance on OpenAI is a key risk—OpenAI’s $300B+ five-year deal starting in 2027 could represent nearly half of Oracle’s remaining obligations, while doubts remain about OpenAI’s ability to pay. Valuation is a modest positive for Oracle (25x P/E vs. IBM at 26x), but the article frames the setup as uncertain given backlog collectability and Oracle’s ~40% stock drawdown over the past year.

Analysis

Oracle’s equity now looks like a financing-quality story as much as a cloud story: the market is implicitly assigning near-equal probability to revenue conversion and customer survival. That creates a subtle asymmetry—near-term multiple support can persist if AI capex spend keeps compounding, but the stock is vulnerable to any sign that backlog is less monetizable than reported, especially if the customer concentration narrative spreads from equity into credit spreads.

IBM is the cleaner balance-sheet/earnings-duration trade, but the problem is not risk—it’s scarcity of upside. Z can lift sentiment, yet it is too small to re-rate the whole franchise unless the rest of software accelerates; otherwise the market will keep valuing IBM like a steady compounder rather than an AI winner. In relative terms, that makes IBM more of a defensive long than a growth long.

The second-order beneficiary set is the infrastructure stack around Oracle: networking, power, and data-center capacity providers should continue to see demand as long as OCI capex stays elevated. The flip side is that if capital markets tighten, the weakest link is not Oracle’s reported backlog but the funding path behind it; that risk is months-to-years, not days, and it can hit the multiple before the revenue line does.

Contrarian view: the market may be over-penalizing Oracle for a 2027 problem while underpricing the option value of today’s growth runway. But if OpenAI funding headlines deteriorate or OCI growth decelerates below the implied trajectory next quarter, the thesis breaks quickly because the stock is being priced on trust in conversion, not just bookings.

Key Decisions for Investors

• Pair trade: long IBM / short ORCL for 1-3 months if you want to express backlog-quality skepticism with lower beta; target 5-10% relative outperformance for IBM if Oracle sentiment cools, stop if ORCL re-accelerates cloud guidance or backlog conversion improves.
• If already long ORCL, hedge with near-dated downside protection into the next earnings cycle; a 2-3 month put spread is the cleaner expression because the main risk is a sentiment reset on customer funding, not an immediate earnings miss.
• Watch ORCL credit and any AI-customer financing headlines over the next 1-2 quarters; if CDS/spreads widen or there is any delay in major contract monetization, reduce equity exposure first because the multiple will likely compress before revenue does.
• For a cleaner AI infrastructure exposure, prefer basket longs in ANET/AMAT-style picks-and-shovels over single-name ORCL; the risk/reward is better when demand is broad-based rather than concentrated in one large customer.
• Do not chase IBM for upside unless software growth broadens beyond Z; treat it as a defensive hold only, with a 6-12 month horizon and limited re-rating potential unless the next two prints show segment-wide acceleration.